JP2015511604A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015511604A5 JP2015511604A5 JP2015500545A JP2015500545A JP2015511604A5 JP 2015511604 A5 JP2015511604 A5 JP 2015511604A5 JP 2015500545 A JP2015500545 A JP 2015500545A JP 2015500545 A JP2015500545 A JP 2015500545A JP 2015511604 A5 JP2015511604 A5 JP 2015511604A5
- Authority
- JP
- Japan
- Prior art keywords
- acute lymphoblastic
- composition
- lymphoblastic leukemia
- leukemia
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261610722P | 2012-03-14 | 2012-03-14 | |
| US61/610,722 | 2012-03-14 | ||
| PCT/US2013/030748 WO2013138430A1 (en) | 2012-03-14 | 2013-03-13 | Compounds and methods for treating leukemia |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015511604A JP2015511604A (ja) | 2015-04-20 |
| JP2015511604A5 true JP2015511604A5 (cg-RX-API-DMAC10.html) | 2016-03-10 |
| JP6424155B2 JP6424155B2 (ja) | 2018-11-14 |
Family
ID=49161751
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015500545A Active JP6424155B2 (ja) | 2012-03-14 | 2013-03-13 | 白血病を治療するための化合物および方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9315481B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP2825162B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP6424155B2 (cg-RX-API-DMAC10.html) |
| KR (1) | KR20140136436A (cg-RX-API-DMAC10.html) |
| CN (2) | CN104244934A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2013232208B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2865437A1 (cg-RX-API-DMAC10.html) |
| ES (1) | ES2689665T3 (cg-RX-API-DMAC10.html) |
| IL (1) | IL234273A (cg-RX-API-DMAC10.html) |
| MX (1) | MX356102B (cg-RX-API-DMAC10.html) |
| RU (1) | RU2672553C2 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2013138430A1 (cg-RX-API-DMAC10.html) |
| ZA (1) | ZA201406172B (cg-RX-API-DMAC10.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX357284B (es) * | 2011-05-26 | 2018-07-04 | Univ Indiana Res & Tech Corp | Compuestos de quinona para tratar enfermedades mediadas por ape1. |
| BR112017024552A2 (pt) | 2015-05-21 | 2018-07-24 | Univ Indiana Res & Tech Corp | métodos para direcionar ape1/ref-1 para inibir os genes de sinalização da hipóxia |
| WO2018140286A1 (en) * | 2017-01-25 | 2018-08-02 | Indiana University Research And Technology Corporation | Prophylaxis and treatment of acute myeloid leukemia |
| JP2020514349A (ja) * | 2017-03-20 | 2020-05-21 | インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションＩｎｄｉａｎａ Ｕｎｉｖｅｒｓｉｔｙ Ｒｅｓｅａｒｃｈ Ａｎｄ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏｒｐｏｒａｔｉｏｎ | 癌の処置のための併用治療剤におけるａｐｅ１／ｒｅｆ−１阻害剤の使用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5627165A (en) | 1990-06-13 | 1997-05-06 | Drug Innovation & Design, Inc. | Phosphorous prodrugs and therapeutic delivery systems using same |
| CA2429005A1 (en) * | 2001-09-17 | 2003-03-27 | Daiichi Suntory Pharma Co., Ltd. | Substituted benzoic acid derivatives having nf-kb inhibiting action |
| CN100343237C (zh) * | 2002-06-28 | 2007-10-17 | 日本新药株式会社 | 酰胺衍生物及医药品 |
| FR2900150B1 (fr) * | 2006-04-25 | 2012-07-06 | Fluofarma | Composes de type 1,4-naphtoquinones, compositions les comprenant et utilisation de ces composes en tant qu'agent anti-cancereux |
| JP2010512407A (ja) * | 2006-12-11 | 2010-04-22 | ジェネンテック インコーポレイテッド | 新生物を処置するための組成物および方法 |
| BRPI0817293A2 (pt) * | 2007-09-26 | 2015-06-16 | Univ Indiana Res & Tech Corp | Derivado de benzoquinona e3330 em combinação com agentes quimioterapêuticos para o tratamento de câncer e angiogenese |
| CN102215833B (zh) * | 2007-11-21 | 2014-11-05 | 印第安纳大学研究及科技有限公司 | 苯醌衍生物e3330联合化疗剂用于治疗癌症和血管生成 |
| US8436171B2 (en) * | 2008-02-01 | 2013-05-07 | Akinion Pharmaceuticals Ab | Amino substituted pyrazines as inhibitors or protein kinases |
| MX357284B (es) * | 2011-05-26 | 2018-07-04 | Univ Indiana Res & Tech Corp | Compuestos de quinona para tratar enfermedades mediadas por ape1. |
| US20140128398A1 (en) * | 2011-06-03 | 2014-05-08 | Indiana University Research And Technology Corporation | Compounds, compositions and methods for treating oxidative dna damage disorders |
-
2013
- 2013-03-13 CN CN201380013870.6A patent/CN104244934A/zh active Pending
- 2013-03-13 CN CN201811324380.9A patent/CN109602734A/zh active Pending
- 2013-03-13 JP JP2015500545A patent/JP6424155B2/ja active Active
- 2013-03-13 AU AU2013232208A patent/AU2013232208B2/en active Active
- 2013-03-13 MX MX2014010275A patent/MX356102B/es active IP Right Grant
- 2013-03-13 WO PCT/US2013/030748 patent/WO2013138430A1/en not_active Ceased
- 2013-03-13 EP EP13761860.9A patent/EP2825162B1/en active Active
- 2013-03-13 KR KR20147024023A patent/KR20140136436A/ko not_active Ceased
- 2013-03-13 RU RU2014141152A patent/RU2672553C2/ru not_active IP Right Cessation
- 2013-03-13 ES ES13761860.9T patent/ES2689665T3/es active Active
- 2013-03-13 US US14/384,814 patent/US9315481B2/en active Active
- 2013-03-13 CA CA2865437A patent/CA2865437A1/en not_active Abandoned
-
2014
- 2014-08-21 ZA ZA2014/06172A patent/ZA201406172B/en unknown
- 2014-08-24 IL IL234273A patent/IL234273A/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12018501807A1 (en) | Pyrazolopyrrolidine derivatives and their use in the treatment of diseas | |
| WO2015081133A3 (en) | Nucleotides for the treatment of liver cancer | |
| HRP20250119T1 (hr) | Kdm1a inhibitor i njegova primjena u terapiji | |
| JP2016508134A5 (cg-RX-API-DMAC10.html) | ||
| JP2016518337A5 (cg-RX-API-DMAC10.html) | ||
| JP2015078230A5 (cg-RX-API-DMAC10.html) | ||
| WO2014078778A3 (en) | Antiviral azasugar-containing nucleosides | |
| JP2016515561A5 (cg-RX-API-DMAC10.html) | ||
| IL295418B1 (en) | Beta-d-2'-deoxy-2' alpha-fluoro-2'-bata-c-modified-2-different-n6-purine modified nucleotides for the treatment of hepatitis c virus | |
| HK1224297A1 (zh) | 布罗莫结构域抑制剂 | |
| JP2015504081A5 (cg-RX-API-DMAC10.html) | ||
| JP2016525097A5 (cg-RX-API-DMAC10.html) | ||
| WO2013163244A8 (en) | Imidazothiadiazole derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation | |
| MX2015016344A (es) | Derivados de imidazo-pirrolidinona y su uso en el tratamiento de enfermedades. | |
| WO2016044556A3 (en) | Arginine methyltransferase inhibitors and uses thereof | |
| WO2015021358A3 (en) | Compounds and methods for inhibiting phosphate transport | |
| MX2020001717A (es) | Inhibidores macrociclicos de mcl-1 y metodos de uso. | |
| MX2014012741A (es) | Derivados de imidazotiadiazol e imidazopirazina como inhibidores del receptor 4 activado de proteasa (par4) para tratamiento de agregacion plaquetaria. | |
| JP2015500225A5 (cg-RX-API-DMAC10.html) | ||
| WO2011113060A3 (en) | Antiviral compounds and methods of use thereof | |
| PH12017502376A1 (en) | Oral solid formulation containing irinotecan and method of preparing the same | |
| JP2016539157A5 (cg-RX-API-DMAC10.html) | ||
| GEAP202014683A (en) | 3-tetrazolyl-benzene-1,2-disulfonamide derivatives as metallo-beta-lactamase inhibitors | |
| JOP20190086A1 (ar) | مشتقات نافثيريدينون جديدة واستخدامها في معالجة عدم انتظام ضربات القلب | |
| CN109689652A (zh) | 稠杂环类衍生物、其制备方法及其在医学上的应用 |